Healthcare & Life Sciences

Rose Pharma Inc

United Statesrosepharmainc.com/presenting-phase-2a-results-of-rose-010-at-obesity-week-2025/
alive
Sign in to unlockWebsite

About

Rose Pharma Inc. is a clinical-stage biopharmaceutical company developing ROSE-010, a patented short-acting GLP-1 analogue aimed at weight management, including weight-loss maintenance, and acute irritable bowel syndrome pain relief.

Explore Rose Pharma Inc's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing